Change search
ReferencesLink to record
Permanent link

Direct link
AcureOmics AB.
Umeå University, Faculty of Science and Technology, Department of Chemistry. (Computational life science cluster (CLiC))
AcureOmics AB.
Anamar AB.
2012 (English)Patent (Other (popular science, discussion, etc.))
Abstract [en]

Abstract: The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in such profiles in a subject which are caused by or correlated with the said diseases or disorders. Such disturbances can be normalised by treatment of the subject with specified compounds, particularly N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine or an aminoguanidine.

Place, publisher, year, edition, pages
National Category
Diagnostic Biotechnology
URN: urn:nbn:se:umu:diva-88201OAI: diva2:714281
Available from: 2014-04-25 Created: 2014-04-25 Last updated: 2014-04-25

Open Access in DiVA

No full text

By organisation
Department of Chemistry
Diagnostic Biotechnology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 204 hits
ReferencesLink to record
Permanent link

Direct link